We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Okta
OKTA
$23.7B
| $30.9M | 0.42% |
+144,430
| New | +$30.1M |
|
27
Honeywell
HON
$78B
| $30.5M | 0.41% |
196,290
-122,258
| -38% | -$18.2M |
|
28
Herbalife
HLF
$1.22B
| $30.1M | 0.41% |
645,309
+213,296
| +49% | +$10.5M |
|
29
Meta Platforms (Facebook)
META
$1.54T
| $30M | 0.4% |
114,599
+39,741
| +53% | +$10.2M |
|
30
Moody's
MCO
$82.5B
| $30M | 0.4% |
+103,451
| New | +$29.5M |
|
31
lululemon athletica
LULU
$12.6B
| $29.7M | 0.4% |
90,118
+49,642
| +123% | +$16.6M |
|
32
O'Reilly Automotive
ORLY
$71.4B
| $29.6M | 0.4% |
964,125
-28,425
| -3% | -$864K |
|
33
Baxter International
BAX
$11.2B
| $29.5M | 0.4% |
366,333
+249,946
| +215% | +$21M |
|
34
iShares Biotechnology ETF
IBB
$9.35B
| $29.3M | 0.39% |
+216,035
| New | +$29.3M |
|
35
Tyson Foods
TSN
$20B
| $29.1M | 0.39% |
489,591
+17,175
| +4% | +$1.06M |
|
36
Gilead Sciences
GILD
$162B
| $28.9M | 0.39% |
458,130
+441,687
| +2,686% | +$30.6M |
|
37
Citigroup
C
$221B
| $28.6M | 0.39% |
664,182
+181,680
| +38% | +$9.05M |
|
38
Bristol-Myers Squibb
BMY
$126B
| $28.5M | 0.38% |
472,434
-93,159
| -16% | -$5.61M |
|
39
Etsy
ETSY
$7.68B
| $28.4M | 0.38% |
233,707
-38,411
| -14% | -$4.5M |
|
40
Cisco
CSCO
$444B
| $28.3M | 0.38% |
717,921
+582,216
| +429% | +$25.4M |
|
41
State Street SPDR S&P Biotech ETF
XBI
$10.2B
| $28.2M | 0.38% |
+253,465
| New | +$28.4M |
|
42
Wells Fargo
WFC
$261B
| $28M | 0.38% |
1,190,614
+455,455
| +62% | +$11.2M |
|
43
CME Group
CME
$91.9B
| $28M | 0.38% |
167,100
-65,553
| -28% | -$11M |
|
44
GoDaddy
GDDY
$11.6B
| $27.1M | 0.36% |
356,456
+299,302
| +524% | +$22.6M |
|
45
Omnicom Group
OMC
$22.2B
| $27.1M | 0.36% |
546,564
+229,185
| +72% | +$12.3M |
|
46
Domino's
DPZ
$10.7B
| $26.9M | 0.36% |
63,243
-5,277
| -8% | -$2.1M |
|
47
Linde
LIN
$234B
| $26M | 0.35% |
109,125
+29,825
| +38% | +$7.23M |
|
48
PayPal
PYPL
$49.4B
| $25.9M | 0.35% |
131,429
+73,937
| +129% | +$13.9M |
|
|
VAR
49
DELISTED
Varian Medical Systems, Inc.
VAR
| $25.5M | 0.34% |
+148,310
| New | +$23.3M |
|
50
Alphabet (Google) Class A
GOOGL
$3.89T
| $25.3M | 0.34% |
345,720
+87,820
| +34% | +$6.69M |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.